We have developed a model of peripheral in vivo T cell tolerance that is induced by administration of the protein superantigen staphylococcal enterotoxin B (SEB). Rather than activating V08+ T cells, in vivo administration of SEB induced in them a profound state of anergy. This was shown by their failure to proliferate to subsequent in vitro restimulation with SEB or to antiV08 antibodies. This unresponsiveness was V08 specific since T cells from SEB-immunized mice responded normally to other antigens. 8 d after SEB administration, there was no reduction in the number of Va8+ T cells or in the intensity of V08 T cell receptor (TCR) expression . Although a portion of the V08+ T cells from SEB-primed mice were able to express interleukin 2 receptors (IIr2Rs), they failed to proliferate in response to exogenous IL2, indicating they were defective in their IL-2 responsiveness. 2-4 wk after SEB administration, there was a reduction of -50% in the number of V08+ cells in immunized compared with control animals . There was, however, no reduction in the level of TCR expression on the remaining V08+ cells. These data demonstrate that proteins that activate T cells in vitro in a V/3-specific manner can induce a state of anergy in peripheral T cells in vivo and may possibly further mediate clonal deletion in a portion of the tolerized cells.
During the development of a functional immune repertoire, antigen-specific components of the immune system must learn to discriminate selffrom non-self. Recent studies have shown that to establish self tolerance many potentially self-reactive T lymphocytes are clonally deleted intrathymically (1) (2) (3) (4) (5) . This has been demonstrated in systems wherein the expression of particular TCR Vii regions correlates with specificity to self antigens such as I-E and minor lymphocyte stimulatory (Mls)l antigens (1) (2) (3) , as well as in TCR transgenic mouse models (4, 5) . Additionally, it was demonstrated that tolerance in the developing immune system can be acquired by functional inactivation (anergy) in the absence of clonal deletion, notably to self antigens expressed only on thymic epithelium (6) or only extrathymically (7) (8) (9) .
Mature peripheral T cells can also be rendered tolerant in vitro (10, 11) and in vivo (10, 12, 13) . The studies on in vivo tolerance induction demonstrated that it is possible to induce tolerance in mature T cells to minor or class I histocompatibility antigens (9, 12), to Mls antigens (12, 13) , and to protein antigens that were coupled to chemically modified APC (10) . Furthermore, tolerance can be induced in mature I Abbreviations used in this paper. Mls, minor lymphocyte stimulatory ; PPD, purified protein derivative ; SE, staphylococcal enterotoxin .
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The Journal of Experimental T cells by soluble protein antigens after both in vivo or in vitro priming (14) (15) (16) (17) (18) (19) . Tolerance induction in these situations was critically dependent upon factors such as the route of administration (either intravenously or oral), and the amount and chemical state of the antigen (monomeric rather than aggregated) . Because TCR usage in these responses was undetermined, it was not possible to distinguish among anergy, clonal deletion, or regulation by suppressor cells as the mechanism of tolerance .
The purpose of the current investigation was to examine the mechanisms of the induction of tolerance in vivo in mature peripheral T cells. In the current study, we demonstrate that T cells from BALB/c mice primed with the superantigen staphylococcal enterotoxin B (SEB) displayed a dramatically diminished response to this antigen upon subsequent in vitro activation . Because SEB has been shown to specifically activate T cells that express V08+ TCRs (20) , we were able to directly assay the activity of V08+ T cells using V/38-specific antibodies . In vivo administration of SEB (either subcutaneously in adjuvant or intravenously) induces a state of profound unresponsiveness in V08+ T cells, yet these cells are present in normal numbers, with no apparent downregulation of the level of TCR expression. The observed unresponsiveness is specific because SEB-immunized animals respond normally to in vitro stimulation with other antigens. Thus, these data demonstrate that a soluble protein that activates T cells in a V(3-specific manner can induce tolerance in peripheral T cells by the induction of clonal anergy.
Materials and Methods
Animals. BALB/c and B10 .BR mice (4-8 wk old) were purchased from either the National Cancer Institute Frederick Animal Research Facility (Frederick, MD) or The Jackson Laboratory (Bar Harbor, ME) . All other inbred strains of mice were purchased from The Jackson Laboratory.
Reagents. SEB was purchased from Sigma Chemical Co. (St . Louis, MO). SEA was purchased from Toxin Technologies (Madison, WI) .
Fluorescence Staining (FACS). Cells were suspended in HBSS (without phenol red) containing 1% BSA and 0 .1% sodium azide (FACS buffer) . Cells (106 /100 pd buffer) were incubated for 30 min on ice with 10 141 of the appropriate FITC-conjugated antibody. For two-color analysis, alter washing, cells were incubated with biotinylated mAb to CD4 or CD8, and then allophycocfanin-labeled avidin (Caltag Laboratories, Inc., San Francisco, CA) . Control staining of cells with irrelevant antibody was used to obtain background fluorescence values. Single-color analysis was done on a FAC-SCAN (Becton Dickinson & Co ., Mountain View, CA) interfaced to a PDP 11/24 computer. Reagents used for direct staining were FITC-or biotin-conjugated anti-: a/Q (21), CD8 (22) , CD4 (23), V03 (24) , V/36 (25) , V08 (26) , and IL2R (27) .
T Cell Proliferation Assays. Mice were immunized in the hind footpad with SEB (50 or 100 Pg/hind foot pad) emulsified in CFA H37Ra (Difco Laboratories Inc., Detroit, MI) or CFA alone . In some experiments, animals were injected with SEB in PBS intravenously through the tail vein. 8, 14, or 30 d later, T cells pooled from either the spleens or lymph nodes of three to five mice/group were isolated by passage over nylon wool . Cultures were performed in flat-bottomed microtiter wells (antigen-induced proliferation assays) or round-bottomed microtiter wells (mAb-induced proliferation assays) in a 1 :1 mixture of Eagle's Hanks Amino Acids medium and RPMI 1640 supplemented with 10% FCS, 2-ME (5 x 10 -5 M), Hepes buffer, glutamine, penicillin, and gentamycin . For antigen-induced proliferation, 105 T cells/well were stimulated with 5 x 105 irradiated (2,000 rad) Thy-1 .2 -(New England Nuclear, Boston, MA) syngeneic spleen cells as a source of APC in the presence of various concentrations of SEB, SEA, or 20 /Ag/ml purified protein derivative (PPD) . After 3 d, cultures were pulsed with 1 /Ci of [3 Hlthymidine (New England Nuclear) and harvested 12-18 h later. For the experiments that assessed the effect of exogenous IIr2 addition, 100 U/ml of rIL2 (Cetus Corp., Emeryville, CA) was added per well at the initiation of the culture period . Thereafter, cell cultures were treated as described above .
To assay V/3-specific proliferation, purified mAbs were diluted to 10 Ag/ml with PBS, and 30 Al was added per microtiter well. Plates were incubated at 37°C for 2-3 h and then washed three times with PBS before use. Various numbers of T cells were added in 100 al medium (see above) and were cultured in a total of 150 1.1 . After 3 d, cultures were pulsed with 1 ACi of ['H]thymidine and harvested 12-18 h later. For all the proliferation assays, the experimental values shown represent the arithmetic means of determinations performed in triplicate wells . SE were invariably <20% of the mean.
Analysis ofIL2R Expression . Nylon wool-purified lymph node T cells (5 x 105 /ml) from BALB/c mice immunized with either
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Anergy Induction in Peripheral T Cells SEB in adjuvant or CFA alone were stimulated with irradiated (2,000 rad) Thy-1 .2 -syngeneic spleen cells (106 /ml) as a source of APC in the presence of 10 jig/ml SEB for 48 h. The culture medium was as described above for the T cell proliferation assays. After 48 h, aliquots of each culture (SEB vs. CFA) were removed and assessed for proliferation by the addition of 1 ACi of ['H)thymidine . Pulsed cells were harvested 12-18 h later. The remainder of the cells were collected, washed once, and purified by density centrifugation over Ficoll-Hypaque (Pharmacia, LKB Biotechnology, Inc., Piscataway, NJ) to remove dead cells. The cells were then stained and analyzed by FACS for their expression of the TCR a/(3, TCR V08, TCR V06, and the IIT2R tx chain .
Results
BALB/c mice (three/group) were immunized with either SEB emulsified in CFA or with CFA alone. Mice administered SEB by this protocol displayed no discernible ill effects and appeared healthy throughout the post-immunization period . 8 d after in vivo priming with SEB, lymph nodes or splenic T cells were assayed for proliferation to SEB, SEA, PPD, and F23 .1 (antiV08) . SEA was used as a control because it is a superantigen that activates V(31+, Vl3+, and Vo11+, but not V08+ T cells (20) . Fig. 1 shows the in vitro proliferation of lymph node T cells from SEB-vs. CFAprimed BALB/c mice after stimulation with SEB and SEA . The proliferation of T cells from SEB-primed mice to SEB was dramatically reduced in comparison with the SEB-induced proliferation of T cells from mice primed with CFA alone (Fig. 1 A) . In contrast, there was no significant difference between the SEA-and PPD-induced proliferative responses of T cells from SEB/CFA vs. CFA-immunized mice (Fig. 1 B) . These results were highly reproducible in several experiments . Because V08+ T cells predominate in the response to SEB, it was possible that the diminished SEB response occurred because SEB administration had eliminated V08+ T cells (SEB also activates V03+ T cells [20] , but BALB/c mice express Mls°a nd thus have eliminated all V03+ T cells by clonal deletion [28, 29] ) . Therefore, we examined the level of V08 expression in the SEB-vs. CFA-primed mice. As shown in Fig.  2 A, the percentage of T cells expressing V08 was comparable in SEB-and CFA-primed animals . There appeared to be no downregulation of the level of TCR on the V08+ cells in SEB-primed animals. Moreover, the total number of T cells present in the lymph nodes and spleens of SEB/CFA-and CFA-primed mice were also comparable (Fig. 2) . In four separate experiments, the mean percentages of tx/a+ T cells expressing V08 8 d after immunization were 27.5 ± 1 .47% for SEB/CFAprimed animals and 28.0 ± 2 .2% for CFAprimed animals. Significantly, both CD4+ and CD8+ T cells were well represented among the V08+ T cells from the SEB-primed mice (Fig. 2 B) .
We next examined the proliferative capacity of V08+ T cells in each group by directly activating T cells with the V08-specific mAb, F23 .1 (Fig. 3 ). The data in Fig . 3 A show a >90% reduction in the F23 .1-induced proliferation in the SEB-primed mice compared with the CFA-primed controls . Because the degree of inhibition of V#8+ T cells was -90% In three independent experiments identical to the one shown here, the mean percent reductions in in vitro SEB-induced proliferation of SEB/CFA vs . CFA-primed T cells were 10 hg/ml SEB, 81.2 t 1 .4% ; 1 leg/ml SEB, 92 .1 ± 2 .1% ; 0 .1'íg/ml SEB, 92 .4 ± 1 .6% ; 0 .01 Wg/ml SEB, 83 .8 ± 5 .3 % . The error bars indicate the SEM of triplicate determinations .
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Rellahan et al . (top) or CFA (bottom) . Percentages in the upper right hand corner of the Vß8 FRCS profiles represent percent of Vß8 * cells as a fraction of total a/ß+ cells. The mean fluorescence intensity for Vß8' cells from SEB/CFA mice was 389, and for Vß8' cells from CFA mice was 395 . The mean overall T cell yields from these mice, calculated from four separate experiments were (no . of T cells per group; three mice in each group) : lymph nodes, CFA-primed mice: 3 .68 ± 1 .1 x 107; lymph nodes, SEB/CFA-primed mice : 3 .39 t 0 .52 x 10 7; spleens, CFA-primed mice: 4 .25 ± 0 .08 x 107; spleens, SEB/CFA-primed mice: 4.95 ± 2.2 x 10 7 . (B) Two-color flow cytometry analysis of cell surface Vß8 vs. CD8 expression on T lymphocytes from BALB/c mice immunized 8 d before with either SEB/CFA (right) or CFA (left) . The percent of cells that were TCR-a/ß " was 74% for SEB/CFA mice, and 83% for CFA mice. The percent of Vß8' cells that were CD8' was 50% for SEB/CFA mice and 38% for CFA mice, while the percent of Vß8' T cells that were CD4+ was 50% for SEB/CFA mice and 60% for CFA mice (not shown) .
and Vß8+ T cells were well distributed among the CD4+ and CD8+ subsets (Fig. 2 B) , it can be inferred that SEB has induced anergy in both subsets because both CD4+ and CD8+ T cells can normally respond to TCR-specific antibodies (30) . Moreover, the proliferation of VQ6+ T cells, which are not reactive with SEB (20) , to stimulation with antiVß6 antibodies was comparable in the SEB-and CFA immunized groups (Fig. 3 B) . These data show that the unresponsiveness induced by in vivo SEB administration was specific and not due to a generalized T cell paralysis. The Vß8-specific anergy was also not strain or MHC specific, such that similar inhibition of the Vß8 proliferative response was observed in B10, B10.BR, B10D2, and C3H/HeJ mice primed with SEB ( Fig . 3 C and data not shown) .
To test whether inhibition was regionally confined to draining lymph nodes, we also examined the proliferative response of splenic T cells from SEB-immunized mice to in vitro SEB stimulation . As shown in Table 1 , there was also a dramatic decrease in the ability of splenic T cells from SEBimmunized animals to proliferate after in vitro restimulation with SEB-relative to CFA-primed controls. These data show that the anergy induced by subcutaneous administration of SEB is not solely a regional effect but exists in T cells removed from the site of SEB administration .
Because one of the classical means of generating peripheral T cell tolerance has been to inject proteins or cells intravenously, we next determined whether SEB would also induce tolerance after intravenous injection. SEB diluted in PBS, or PBS alone, was injected intravenously, and 8 d later, the responses of splenic T cells to stimulation with SEB, SEA, and antiVß8 antibodies were assayed for both groups . The response of T cells from intravenously SEB-immunized animals to in vitro restimulation with both SEB and anti-Vß8 was significantly reduced in comparison with the PBS controls (Fig . 4, A and C) . In contrast, the responses of both groups to stimulation with SEA were comparable (Fig. 4 B) . As with the subcutaneous administration of SEB, 8 d after intravenous administration, there appeared to be no difference in either the percentage of Vß8+ T cells or in the receptor density on Vß8+ cells between mice administered SEB/PBS vs. PBS alone (data not shown) . Also, there was no significant difference between the two groups in the number of splenic T cells recovered (data not shown) . Therefore, these data indicate that the intravenous administration of SEB also results in the specific induction of anergy in Vß8+ peripheral T cells .
We next examined the duration of the SEB-induced tolerance. Profound inhibition persisted for at least 4 wk after in vivo SEB administration (Fig . 5) . Interestingly, however, 2 wk after SEB administration, and thereafter, there was a highly reproducible 50-60% decrease in the number of Vß8 + T cells in SEB-as compared with CFA-primed mice (Fig. 5) . The remaining Vß8+ T cells expressed normal receptor levels (data not shown) . Because the SEB-and anti-Vß8-induced proliferation of T cells from SEB-primed animals was reduced by 80-90%, the decrease in absolute numbers of Vß8+ cells can not fully account for the absence of the Vß8+ T cell response seen in SEB-primed mice . Thus, these data suggest that a proportion of the Vß8+ T cells from SEB-primed mice that are anergic 8 d after priming are deleted by day 14 post-priming, and that the remaining Vß8+ cells persist in an unresponsive state.
To begin to examine the mechanism of SEB-induced unresponsiveness, we studied IL2R expression and the IIr2 responsiveness of SEB-tolerized T cells. In the experiment shown (Fig. 6 ), 2 d after in vitro restimulation with SEB, Vß8+ T cells from SEB-primed mice were able to express IL2R, although this expression was reduced somewhat (50% vs. 76%) when compared with CFA controls . Also, after 2 d of in vitro stimulation with SEB, 42% of the T cells from CFA-primed animals were Vß8+, as compared with only 24% for SEB-primed animals, consistent with the failure of the Vß8+ T cells from these latter mice to proliferate in response to SEB in vitro . The addition of exogenous IL2 at the initiation of culture had little effect on the ability of Vß8 cells to proliferate in response to restimulation with SEB (Fig.  6 ) . This suggests that the anergized T cells are defective in both their ability to express normal levels of IL2R, and to proliferate in response to IL-2.
In the course of our studies, it was found that, although all strains assayed showed Vß8-specific SEB-induced anergy, only BALB/c and C3H/HeJ mice responded with a consistent decrease to in vitro restimulation with SEB (data not shown) . T cells from B10, B10.D2, and B10.BR mice responded inconsistently to in vitro restimulation with SEB. BALB/c and C3H/HeJ mice are Mls°and therefore delete Vß3+ T cells (28, 29) , whereas B10, B10.132, and B10.13R, mice are Mlsb and have peripheral V03' cells. Since SEB is known to activate Vß3+ as well as Vß8+ T cells in vitro (20) , it was possible that in vivo SEB administration was not affecting Vß3+ and Vß8+ T cells equally. To address this issue, lymph node T cells from SEB-immunized B10 mice (Mlsb) were assayed for proliferation to both antiVß8 and antiVß3 plate-bound antibodies . As shown in Fig. 7 , there was a significant reduction in the proliferation of T cells from SEB-immunized animals to antiVß8 stimulation in comparison with control T cells, while their response to antiVß3 stimulation was identical to that of the controls . These data indicate that in vivo administration of SEB induces anergy in a VO-specific manner, such that not all Vß-expressing T cells capable of being activated by SEB in vitro are tolerized after in vivo SEB administration . 
Discussion
The advent of transgenic mice and specific antiTCR reagents has made possible the direct demonstration of intrathymic clonal deletion (1) (2) (3) (4) (5) , and the intrathymic induction of clonal anergy during development (6) . Tolerance of mature peripheral T cells to MHC antigens (12) and Mls antigens (13) has been demonstrated under conditions where T cells expressing TCRs known to be reactive for these antigens were not deleted (were present in normal numbers) . These results suggested that the peripheral tolerance was due to clonal anergy, although direct stimulation with TCRspecific antibodies was not investigated . In this report, we have shown directly the in vivo induction, by a Va-specific mitogen, of T cell tolerance due to clonal anergy . We have found that after the in vivo administration of SEB (either subcutaneously emulsified in CFA, or intravenously in PBS), V08+ T cells become unresponsive to subsequent restimulation with either SEB or antiV08 antibodies (F23.1) . Though previous studies have reported nonspecific immune suppression after in vivo administration of SE (31) (32) (33) , the unresponsiveness we describe in this report is specific since the same cell population will respond normally to restimulation with SEA, PPD, or V03-and V(06-specific antibodies. Other mechanisms to account for this tolerance were ruled out . First, the SEB-induced unresponsiveness does not appear to be due to residual SEB blocking of Va8+ TCRs because F23 .1 was able to stain Va8+ cells from SEB-primed mice with the same intensity as Va8+ cells from CFA-primed mice, suggesting that SEB is not blocking the binding of F23.1 to 1096 Anergy Induction in Peripheral T Cells 
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TCRs. In addition, mixing experiments with cells from CFA-and SEB-primed animals eliminated the possibility that suppressor cells were responsible for the tolerance (data not shown) .
The fact that SEB belongs to the group of superantigens that stimulate T cells on the basis of V(d expression alone suggests a possible mechanism to explain tolerance induction in this system . Recent studies have shown a rise in intracellular Cal+ levels and modulation of the TCR complex after T cell clones were incubated with SEB in the absence of APC (34) . This suggests that SEB can directly bind and induce signaling through the TCR . Because an increase in intracellular Caz+ levels in the absence of other accessory signals has been suggested as one mechanism for tolerance induction in vitro (10, 35, 36) ; it is possible that SEB induces anergy in VQ8+ cells because it is able to directly bind and induce signaling through the TCR in the absence of accessory signals provided by APC . The failure of SEB to tolerize V03+ T cells in vivo while it does tolerize V08+ T cells may reflect differences in the relative affinity that SEB has for V(33 vs . V08 TCRs .
SEs have also been shown to bind directly to class 11 molecules with high affinity (37, 38) , and the in vitro stimulatory effect of SEs is believed to be based on their ability to crosslink the TCRs on T cells with class II molecules on APC (34, 39) in the absence of antigen processing . Thus, tolerance induction by SEB could also result from a very high affinity interaction between the SE/la complex and the TCR, (11) CFA primed, with IL-2 . Nylon wool-purified lymph node T cells from SEB/CFA-or CFA-immunized mice (four/group) were stimulated as in Fig . 1 with or without the addition of IL-2 (102 U/ml) . 11,2 was added at the initiation of the culture period .
perhaps involving predominant presentation by B lymphocytes, which are relatively poor at providing accessory signals (40) (41) (42) . In this context, it was recently shown that the relative potency of peptide antigens in vitro correlated directly with their capacity to induce tolerance in vivo (43) . Moreover, in the murine experimental allergic encephalomyelitis model, analogues of the encephalitogenic MBP-1-9 peptide that were more potent than the native peptide at activating encephalitogenic T cell clones in vitro paradoxically were protective against disease when administered in vivo (44) . It was suggested that the in vivo administration of such peptides could result in the tolerization of the encephalitogenic T cell clones by clonal anergy (44) . SEs have also been shown to activate T cells in vivo, and it has been demonstrated that T cell activation and lymphokine release may be responsible for some of the manifestations of systemic staphylococcal infection (33) . It 1097
Rellahan et al . would be of interest to define the parameters of toxin administration that lead alternatively to T cell activation or the induction of tolerance . 2 wk after SEB administration, Vß8+ T cells were diminished in number, although the remainder were still anergic. The intensity of Vß8 expression on these cells appears to be normal, indicating that the decrease in Vß8 cells is not due to receptor downregulation . It is also doubtful that the diminished number of Vß8+ T cells after 2 wk is due to SEBinduced intrathymic deletion because the decrease consistently occurs between day 8 and 14 post-immunization, and it is unlikely that 40-50% of all peripheral Vß8+ cells are normally replaced during a 6-d period . In addition, preliminary experiments indicate that there is minimal downregulation of Vß8 on cortisone-resistant thymocytes 8 d after subcutaneous SEB administration (unpublished data) . Therefore, these data suggest that in vivo administration of SEB may result in the clonal deletion of some peripheral Vß8+ T cells.
The fact that some Vß8+ cells first appear to be anergized and then proceed to clonal deletion suggests that the clonal anergy observed and the subsequent deletion of a portion of the anergized cells may be discrete stages of a continuing process. Recent studies demonstrate some similarities between the intracellular mechanisms leading to anergy and to clonal deletion, such as dependence on an early TCR-CD3-mediated Cal+ flux, and sensitivity to cyclosporine A (45-50) . However, clonal deletion is not an inevitable consequence of anergy induction because at least 50% of the Vß8+ cells were able to persist in a state of anergy. In addition, in other reported examples of T cell tolerance due to anergy, the anergized cells were not clonally deleted and persisted for extended periods of time (6, 13) . The decision to progress from anergy to deletion could depend on factors such as the maturation state of the T cell, or the intensity and duration of the stimulus a cell receives through its TCR (51) .
In vitro models of T cell anergy suggest that a major defect in these cells is their inability to produce IL2. In the case of in vitro anergized cells, the anergized T cell clones were still fully responsive to exogenously added 11,2 (50) . However, our model of in vivo induced anergy, as well as that of others (6, 13) , suggest the defect is more generalized than this. Upon in vitro restimulation with SEB, -40-50% of the V08' T cells from SEB-primed mice express normal levels of IL2Rs. The remainder either do not express IL2Rs at all or do so at undetectable levels . Even so, all these cells are only minimally responsive to exogenous IL-2. The fact that 50% of the V08+ cells can be IL2R+ but are nevertheless unresponsive to exogenous IL2 suggests that stages of activation in addition to the production of IL2 are blocked in peripherally anergized T cells. These additional defects may be at the level of IL2R expression (i .e., an ability to express high affinity IL-2 receptors), or an inability to transmit the signal normally delivered by 11,2. Although other models of in vivo T cell anergy also find that anergized cells are only minimally responsive to exogenous IL2 (6, 13) , in the case of Rammensee et al . (13) , the anergic V06+ cells rendered tolerant after the in vivo administration of Mls, spleen cells expressed normal levels of IL2Rs after activation .
Although soluble protein antigens have long been used to study the induction of tolerance in both T and B cells, they were ineffective as tolerogens if administered subcutaneously, particularly if emulsified in adjuvant . Most proteins studied as tolerogens were administered intravenously or orally, in an unaggregated form, or at very high doses or very low doses (15) (16) (17) (18) (19) . SEB thus differs from conventional protein antigens in that it induces anergy when administered subcutaneously in CFA as well as intravenously. This may reflect the fact that the trimolecular interaction between SE, the la molecule, and the TCR is very likely to be distinct from that of conventional protein antigens (52, 53) . Superantigens may bind directly to Ia molecules outside the putative antigen binding groove, and in view of their activation of T cells based on TCR V/3 expression alone, they probably interact with a region of the V(3 protein not involving the third complementarity determining region formed by VDJ recombination (52, 53) . If this is true, it raises the possibility that if the mechanism by which SEs bind to specific V(3 TCRs can be understood, it may be possible to design peptides that mimic this binding and that can be used to suppress or amplify immune responses in a T cell Va-specific manner. Such peptides could be useful to specifically control autoimmune diseases that are mediated by a limited set of V(3+ T cells (54) (55) (56) .
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